In a phase 2a trial of 40 adults (43 enrolled) with infected, non-draining pleural effusions, intrapleural single chain urokinase (LTI-01) did not significantly reduce 7-day treatment failure versus placebo (OR 1.04, P=0.96). No pleural or lung bleeding was seen.
RCTn = 43
Lamb et al. The LTI-01-2001 phase 2a trial of intrapleural LTI-01 in patients with infected, non-draining pleural effusions